Alerts will be sent to your verified email
Verify Email
REMUS
|
Remus Pharmaceutical
|
Oswal Agro Mills
|
Uniphos Enterprises
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
38.78 % | 2.59 % | 1.16 % |
|
5yr Avg Net Profit Margin
|
12.12 % | 160.92 % | 2029.38 % |
|
Price to Book
|
0.0 | 1.1 | 0.39 |
|
P/E
|
36.48 | 8.29 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
62.15 Days | 0.0 | -3.66 Days |
|
5yr Average Interest Coverage Ratio
|
52.6 | 92.52 | 0.76 |
|
5yr Avg ROCE
|
46.86 % | 1.1 % | 1.14 % |
|
5yr Avg Operating Profit Margin
|
14.35 % | -119.74 % | -165.57 % |
|
5 yr average Debt to Equity
|
0.17 | 0.0 | 0.0 |
|
5yr CAGR Net Profit
|
83.69 % | -32.41 % | -59.1 % |
|
5yr Average Return on Assets
|
16.02 % | 2.56 % | 1.14 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.85 % | 46.89 % | 73.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.24 % | 5.15 % | 0.01 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Remus Pharmaceutical
|
Oswal Agro Mills
|
Uniphos Enterprises
|
|---|